Source-grounded facts extracted from Pennant Group, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Pennant Group, Inc. reported first quarter ended March 31, 2026 results: revenue $285.4 million, net income $8.5 million, EPS $0.24.
“quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.32 for the quarter (1) . First Quarter Highlights ▪ Total revenue for the first quarter was $285.4 million, an increase of $75.5 million or 36.0% over the prior year quarter; ▪ Net income for the first quarter was $8.5 million, a increase of $0.7 million or 9.6% over the prior year”
Pennant Group, Inc. incurred term loan of $100,000,000 with Truist Bank, as administrative agent.
“Pursuant to the First Amendment, the Company obtained an incremental term loan A facility in an aggregate principal amount of $100,000,000 (the “Incremental Term Loans”).”
Pennant Group, Inc. completed an acquisition involving UnitedHealth Group Incorporated, Amedisys, Inc. and certain other sellers for $146,531,160 in cash (closed 2025-10-01).
“to the business of providing home health, hospice, or palliative care services through certain providers (the “Transaction”). The total consideration for the Transaction was $146,531,160 in cash, which is subject to certain post-closing adjustments pursuant to the Purchase Agreement, as amended by the Amendment. Except for the Transaction, there are no material”
Pennant Group, Inc. reported preliminary financial results for the first quarter ended March 31, 2024.
“On May 6, 2024 The Pennant Group, Inc. (the “Company” ) issued a press release reporting the financial results of the Company for its first quarter ended March 31, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.